Cargando…
Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13)
BACKGROUND: Early data on COVID-19 (based primarily on PCR testing) indicated a low burden in Sub-Saharan Africa. To better understand this, this study aimed to estimate the incidence rate and identify predictors of SARS-CoV-2 seroconversion in the two largest cities of Burkina Faso. This study is p...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258776/ https://www.ncbi.nlm.nih.gov/pubmed/37308819 http://dx.doi.org/10.1186/s12879-023-08361-2 |
_version_ | 1785057537109786624 |
---|---|
author | Kaboré, Nongodo Firmin Ouédraogo, Samiratou Mamguem, Ariane Kamga Traoré, Isidore Tiandiogo Kania, Dramane Badolo, Hermann Sanou, Guillaume Koné, Amariane Yara, Mimbouré Kagoné, Thérèse Ouédraogo, Esperance Konaté, Blahima Médah, Rachel de Rekeneire, Nathalie Poda, Armel Diendéré, Arnaud Eric Ouédraogo, Boukary Billa, Oumar Paradis, Gilles Dabakuyo-Yonli, Tienhan Sandrine Tinto, Halidou |
author_facet | Kaboré, Nongodo Firmin Ouédraogo, Samiratou Mamguem, Ariane Kamga Traoré, Isidore Tiandiogo Kania, Dramane Badolo, Hermann Sanou, Guillaume Koné, Amariane Yara, Mimbouré Kagoné, Thérèse Ouédraogo, Esperance Konaté, Blahima Médah, Rachel de Rekeneire, Nathalie Poda, Armel Diendéré, Arnaud Eric Ouédraogo, Boukary Billa, Oumar Paradis, Gilles Dabakuyo-Yonli, Tienhan Sandrine Tinto, Halidou |
author_sort | Kaboré, Nongodo Firmin |
collection | PubMed |
description | BACKGROUND: Early data on COVID-19 (based primarily on PCR testing) indicated a low burden in Sub-Saharan Africa. To better understand this, this study aimed to estimate the incidence rate and identify predictors of SARS-CoV-2 seroconversion in the two largest cities of Burkina Faso. This study is part of the EmulCOVID-19 project (ANRS-COV13). METHODS: Our study utilized the WHO Unity protocol for cohort sero-epidemiological studies of COVID-19 in general population. We conducted random sampling stratified by age group and sex. Individuals aged 10 years and older in the cities of Ouagadougou and Bobo-Dioulasso, Burkina Faso were included and surveyed at 4 time points, each 21 days apart, from March 3 to May 15, 2021. WANTAI SARS-CoV-2 Ab ELISA serological tests were used to detect total antibodies (IgM, IgG) in serum. Predictors were investigated using Cox proportional hazards regression. RESULTS: We analyzed the data from 1399 participants (1051 in Ouagadougou, 348 in Bobo-Dioulasso) who were SARS-CoV-2 seronegative at baseline and had at least one follow-up visit. The incidence rate of SARS-CoV-2 seroconversion was 14.3 cases [95%CI 13.3–15.4] per 100 person-weeks. The incidence rate was almost three times higher in Ouagadougou than in Bobo-Dioulasso (Incidence rate ratio: IRR = 2.7 [2.2–3.2], p < 0.001). The highest incidence rate was reported among women aged 19–59 years in Ouagadougou (22.8 cases [19.6–26.4] per 100 person-weeks) and the lowest among participants aged 60 years and over in Bobo-Dioulasso, 6.3 cases [4.6–8.6] per 100 person-weeks. Multivariable analysis showed that participants aged 19 years and older were almost twice as likely to seroconvert during the study period compared with those aged 10 to 18 years (Hazard ratio: HR = 1.7 [1.3–2.3], p < 0.001). Those aged 10–18 years exhibited more asymptomatic forms than those aged 19 years and older, among those who achieved seroconversion (72.9% vs. 40.4%, p < 0.001). CONCLUSION: The spread of COVID-19 is more rapid in adults and in large cities. Strategies to control this pandemic in Burkina Faso, must take this into account. Adults living in large cities should be the priority targets for vaccination efforts against COVID-19. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08361-2. |
format | Online Article Text |
id | pubmed-10258776 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102587762023-06-13 Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13) Kaboré, Nongodo Firmin Ouédraogo, Samiratou Mamguem, Ariane Kamga Traoré, Isidore Tiandiogo Kania, Dramane Badolo, Hermann Sanou, Guillaume Koné, Amariane Yara, Mimbouré Kagoné, Thérèse Ouédraogo, Esperance Konaté, Blahima Médah, Rachel de Rekeneire, Nathalie Poda, Armel Diendéré, Arnaud Eric Ouédraogo, Boukary Billa, Oumar Paradis, Gilles Dabakuyo-Yonli, Tienhan Sandrine Tinto, Halidou BMC Infect Dis Research BACKGROUND: Early data on COVID-19 (based primarily on PCR testing) indicated a low burden in Sub-Saharan Africa. To better understand this, this study aimed to estimate the incidence rate and identify predictors of SARS-CoV-2 seroconversion in the two largest cities of Burkina Faso. This study is part of the EmulCOVID-19 project (ANRS-COV13). METHODS: Our study utilized the WHO Unity protocol for cohort sero-epidemiological studies of COVID-19 in general population. We conducted random sampling stratified by age group and sex. Individuals aged 10 years and older in the cities of Ouagadougou and Bobo-Dioulasso, Burkina Faso were included and surveyed at 4 time points, each 21 days apart, from March 3 to May 15, 2021. WANTAI SARS-CoV-2 Ab ELISA serological tests were used to detect total antibodies (IgM, IgG) in serum. Predictors were investigated using Cox proportional hazards regression. RESULTS: We analyzed the data from 1399 participants (1051 in Ouagadougou, 348 in Bobo-Dioulasso) who were SARS-CoV-2 seronegative at baseline and had at least one follow-up visit. The incidence rate of SARS-CoV-2 seroconversion was 14.3 cases [95%CI 13.3–15.4] per 100 person-weeks. The incidence rate was almost three times higher in Ouagadougou than in Bobo-Dioulasso (Incidence rate ratio: IRR = 2.7 [2.2–3.2], p < 0.001). The highest incidence rate was reported among women aged 19–59 years in Ouagadougou (22.8 cases [19.6–26.4] per 100 person-weeks) and the lowest among participants aged 60 years and over in Bobo-Dioulasso, 6.3 cases [4.6–8.6] per 100 person-weeks. Multivariable analysis showed that participants aged 19 years and older were almost twice as likely to seroconvert during the study period compared with those aged 10 to 18 years (Hazard ratio: HR = 1.7 [1.3–2.3], p < 0.001). Those aged 10–18 years exhibited more asymptomatic forms than those aged 19 years and older, among those who achieved seroconversion (72.9% vs. 40.4%, p < 0.001). CONCLUSION: The spread of COVID-19 is more rapid in adults and in large cities. Strategies to control this pandemic in Burkina Faso, must take this into account. Adults living in large cities should be the priority targets for vaccination efforts against COVID-19. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08361-2. BioMed Central 2023-06-12 /pmc/articles/PMC10258776/ /pubmed/37308819 http://dx.doi.org/10.1186/s12879-023-08361-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Kaboré, Nongodo Firmin Ouédraogo, Samiratou Mamguem, Ariane Kamga Traoré, Isidore Tiandiogo Kania, Dramane Badolo, Hermann Sanou, Guillaume Koné, Amariane Yara, Mimbouré Kagoné, Thérèse Ouédraogo, Esperance Konaté, Blahima Médah, Rachel de Rekeneire, Nathalie Poda, Armel Diendéré, Arnaud Eric Ouédraogo, Boukary Billa, Oumar Paradis, Gilles Dabakuyo-Yonli, Tienhan Sandrine Tinto, Halidou Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13) |
title | Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13) |
title_full | Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13) |
title_fullStr | Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13) |
title_full_unstemmed | Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13) |
title_short | Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13) |
title_sort | incidence rate and predictors of covid-19 in the two largest cities of burkina faso - prospective cohort study in 2021 (anrs-cov13) |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258776/ https://www.ncbi.nlm.nih.gov/pubmed/37308819 http://dx.doi.org/10.1186/s12879-023-08361-2 |
work_keys_str_mv | AT kaborenongodofirmin incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT ouedraogosamiratou incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT mamguemarianekamga incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT traoreisidoretiandiogo incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT kaniadramane incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT badolohermann incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT sanouguillaume incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT koneamariane incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT yaramimboure incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT kagonetherese incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT ouedraogoesperance incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT konateblahima incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT medahrachel incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT derekeneirenathalie incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT podaarmel incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT dienderearnauderic incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT ouedraogoboukary incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT billaoumar incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT paradisgilles incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT dabakuyoyonlitienhansandrine incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 AT tintohalidou incidencerateandpredictorsofcovid19inthetwolargestcitiesofburkinafasoprospectivecohortstudyin2021anrscov13 |